Full text is available at the source.
Metabolic and bariatric surgery versus glucagon-like peptide-1 receptor agonist therapy: A comparison of cardiovascular outcomes in patients with obesity
Heart health after weight-loss surgery compared to medication in people with obesity
AI simplified
Abstract
MBS was associated with a lower hazard of cardiovascular disease compared to GLP-1 RA therapy.
- The primary composite outcome of cardiovascular disease included heart failure, coronary artery disease, and cerebrovascular disease.
- Patients undergoing metabolic and bariatric surgery had a hazard ratio of 0.54 for cardiovascular disease.
- Incident heart failure was associated with a hazard ratio of 0.45 following metabolic and bariatric surgery.
- Coronary artery disease showed a hazard ratio of 0.54 in patients who underwent metabolic and bariatric surgery.
- Cerebrovascular disease was associated with a hazard ratio of 0.64 in the metabolic and bariatric surgery group.
AI simplified